Stentys Appoints René Spaargaren, MD, as Chief Medical Officer

PARIS--(BUSINESS WIRE)--Stentys (http://www.stentys.com) announced today that it has appointed Dr. René Spaargaren as its Chief Medical Officer (CMO). Stentys is developing the world’s first next-generation drug-eluting stent for treatment of blocked coronary artery bifurcations so that hundreds of thousands of patients might avoid open-chest surgery.

MORE ON THIS TOPIC